Načítá se...
Detection of the YMDD Motif Mutations Rate in Chronic Hepatitis B Patients Treated with Lamivudine
Background and Objectives: Lamivudine is the first nucleoside analogue licensed for the treatment of chronic hepatitis B patients which is effective in suppressing virus replication and results in reduced disease activity. However the most important problem of lamivudine treatment is the emergence o...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Persa |
| Vydáno: |
Qom University of Medical Sciences
2011-06-01
|
| Edice: | Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum |
| Témata: | |
| On-line přístup: | http://journal.muq.ac.ir/library/upload/article/af_325292290.18.7.pdf |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|
Načítá se...